DKC1 and inflammatory bowel disease: The course of IBD following BMT in DC patients is poorly described: some report resolution in patients with RTEL1 mutation (77), while IBD persisted in at least one patient with DKC1 mutation (81). This variable response suggests that the underlying mechanism of disease may extend beyond effects of bone marrow failure.